Abstract: Sheet-like dosage forms that quickly dissolve or disintegrate in an aqueous environment, for the application of active agent combinations for the treatment of hypertension. The dosage forms contain at least two active agents that are suitable for the treatment of hypertension. The antihypertensive agents are selected from the group that encompasses beta receptor blockers, alpha receptor blockers, calcium antagonists, ACE inhibitors, AT1 antagonists, centrally acting antihypertensive agents, direct vasodilators, and diuretics. The use of active agent combinations according to the invention for the production of an oral dosage form for the treatment of high blood pressure, a method for the therapeutic treatment of hypertension, and a method for the production of a sheet-like dosage form are also disclosed.

Abstract: A piston ring having a base body, which comprises a running surface provided with at least one chamber, an upper and a lower flank surface, and an inner circumferential surface, wherein the running surface is provided with at least one PVD layer such that the same is adjusted to the contour of the running surface without completely filling the chamber, wherein the respective edge region is provided with a layer thickness, b that is reduced compared to the layer thickness, a of the chamber as a function of the configuration of the chamber.

Abstract: The invention relates to edible film-shaped cola-flavoured preparations which disintegrate quickly and without leaving a residue when coming in contact with moisture.

Abstract: Sheet-like dosage forms for pain therapy, based on hydrophilic polymers, which rapidly dissolve or disintegrate in an aqueous environment and which release active agent combinations when placed into a body orifice or body cavity, and which are preferably orally administrable, with the dosage form containing an active agent combination consisting of an opioid and a second substance The second active agent is a non-steroidal anti-rheumatic (NSAR) or an antidepressant.

Abstract: Rapidly disintegrating oral dosage forms for the application of active agent combinations for diabetes therapy. The dosage forms contain at least two active agents suitable for treating type-2 diabetes. The antidiabetic active agents are selected from the group comprising sulfonylureas, glitazones, glinides, biguanides, and absorption-delaying agents. The use of the active agent combination to produce an oral dosage form for the treatment of diabetes, a method for the therapeutic treatment of diabetes, and a method for the production of a sheet-like dosage form are also disclosed.

Abstract: A single-use injector is disclosed comprising a housing (10), arranged in which are at least one mechanical spring energy store (50), at least one piston-cylinder unit (100), which can be effectively filled at least for a certain time, at least one piston-actuating ram (60) and at least one triggering unit (80). The spring energy store comprises at least one pre-tensioned spring element. The spring-loaded piston-actuating ram (60) has at least one retaining rod or hook (62), which can be moved transversely, at least in certain regions, and by means of a supporting portion supports the tensioned spring energy store on at least one resting surface of the housing. When actuation occurs, the triggering unit (80) releases the supporting portion to allow it to move away from the resting surface.

Abstract: A preparation having at least one unsaturated fatty acid and the use of at least one unsaturated fatty acid having a chain length of 18 or 20 carbon atoms and of plant drugs containing the unsaturated fatty acid as a free fatty acid or a fatty acid radical of a triglyceride. The fatty acid has a chain length of 18 carbon atoms which are provided with 1 to 3 double bonds and the fatty acid has a chain length of 20 carbon atoms which are provided with 1 to 4 double bonds. The double bond or one of the double bonds are located in position 9 or 11 of the carbon chain. The unsaturated fatty acid is supplied in the all-cis configuration. The at least one unsaturated fatty acid prevents and/or treats or is used for producing a preparation for preventing and/or treating thrombosis and thromboembolic diseases.

Abstract: A sheet-like pharmaceutical preparation (dosage form) that quickly disintegrates on contact with moisture, based on hydrophilic polymers for the release of at least one active agent. The dosage form contains an active agent combination for treating depression, and at least one active agent selected from the antidepressant group of drugs. In addition, the use of such a combination of active agents for the production of an orally administrable pharmaceutical product for the treatment of depression, and the therapeutic treatment of depression by oral administration of one of the named pharmaceutical preparations, is provided.

Abstract: Sheet-like pharmaceutical preparations based on hydrophilic polymers, which rapidly disintegrate upon contact with moisture and which are used to treat dementia-related illnesses The dosage form contains an active agent combination of at least two active agents which are suitable for the treatment of dementia (antidementia agents). The antidementia agents should be chosen from the group comprising acetyl cholinesterase inhibitors (AChE inhibitors) and NMDA antagonists (n-methyl-D-asparaginic acid antagonists). The use of such an active agent combination for producing an orally administrable pharmaceutical product for the treatment of dementia-related illnesses such as Alzheimer's disease, as well as a procedure for the symptomatic treatment of Alzheimer's disease by the oral administration of one of the above pharmaceutical products is also provided.

Abstract: A cylinder/piston unit is disclosed for pre-fill, storage and release when desired of an active substance, such as a medicament. The cylinder/piston unit is provided with a cylinder and with a piston which is guided therein and which is sealed off in a sterile manner by a rubber seal, the cylinder and the piston enclosing a chamber that can be filled at least temporarily with active substance, and the cylinder having at least one discharge element at its front end. For this purpose, the piston resting in a rear position is sealed off relative to the cylinder in a sterile manner by a static front sealing element and by a static rear sealing element. Arranged spatially behind each static sealing element, there is a parking area for receiving the respective sealing element.

Abstract: A closure system for containers used for storing or administering substances in the form of liquids, pastes or powders, which system in one embodiment includes a cap, provided with a through-hole, and a closure element, wherein the cap holds the closure element with a force fit and/or form fit on the container, in the area of the container opening that is to be closed, by means of a catch element present on the container. For this purpose, the end face which surrounds the container opening, and on which the closure element bears, comprises a depression. The closure element is a virus-proof, bacteria-proof and spore-proof film that lies on the end face and, at least in some areas, over the depression. The cap is then fitted in place, an elastomer ring or adhesive ring is arranged between the closure element and the depression and fills the depression.

Abstract: A method is provided for producing an electrically insulating sealing arrangement for a fuel cell stack which comprises a plurality of fuel cell units that succeed one another along a stack direction by means of which the housings of the fuel cell units are connectable to one another in such a way that an adequate electrically insulating effect and adequate mechanical rigidity are ensured even at the high operating temperature. The method involves producing a ceramic metal layer and at least partially converting the metal of the ceramic metal layer into an electrically non conductive compound so as to produce a non conductive boundary layer.

Abstract: A method for varying the flight path of a missile, in particular of a spin-stabilized projectile, which has an outer wall and which is provided with at least one impulse device. The impulse device can be activated deliberately at a defined time during the flight of the missile. The impulse device is arranged with respect to the longitudinal axis of the missile such that, when it is activated, it generates an impulse that initiates a tumbling movement which causes the flight-path of the missile to be shortened or varied. A spin-stabilized projectile is provided with such an impulse device and it is configured so that the impulse device may be triggered during flight so as to initiate the flight-altering tumbling movement.

Abstract: A method for isolating atraric acid from biological material, atraric acid derivatives, the chemical synthesis thereof, and the use of atraric acid and the derivatives thereof for treating or producing a medicament for treating benign prostate hyperplasia, prostate carcinoma or spinobulbar muscular atrophy is provided. In addition, a basic substance for the development of other agents used for treating benign prostate hyperplasia, prostate carcinoma, or spinobulbar muscular atrophy is provided.

Abstract: Processes for the production of a compound of the following formula (I) by converting a compound of formula (II) with 2-pyrrolidone used in excess relative to compound (II) and processes for the production of a compound of formula (III). The latter process includes preparing compound (I); a reduction reaction which yields compound (III) in salt form; and liberating compound (III) from the salt.

Abstract: Connectors for modular framing systems having T-shaped slots are disclosed. The connectors connect framing members to each other or connect floor panels to framing members. Architectural structures and modular framing systems containing the connectors are also disclosed.

Abstract: The invention relates to a cylinder/piston unit having a cylinder and a piston which is guided therein, wherein the cylinder and the piston enclose a chamber which can be filled at least for a time with an additive, and the cylinder has at least one exit element at its front end. Here, the cross section of the chamber or the cross section of the cylinder inner wall is increased at least in regions of the cylinder from the front to the back, wherein the cylinder end having the exit element is at the front. The piston has an elastic skirt at least in the front region, the front outer edge of said elastic skirt defining a cross-sectional area in the case of an unloaded piston, which is greater than an area which is defined by a contour line. The present invention develops a cylinder/piston unit which ensures simple and reliable handling and can be stored for a long time in the filled state, in a manner which is impervious to gas and moisture.

Abstract: In order to produce a seal arrangement for a fuel cell stack which comprises a plurality of fuel cell units that succeed one another in a stack direction wherein each of the fuel cell units comprises a housing incorporating at least one housing part consisting of a metallic material such that it exhibits an adequate electrically insulating effect and adequate mechanical rigidity even at a high operating temperature of the fuel cell stack, it is proposed that the seal arrangement comprises at least one housing part of a first fuel cell unit consisting of a metallic material which is provided with a coating of a ceramic material, wherein the housing part of the first fuel cell unit is brazed to a housing part of a second fuel cell unit by means of a metallic braze at least one position that is provided with the ceramic coating.

Abstract: A sealing structure in a fuel cell and/or an electrolyzer (particularly a solid-oxide fuel cell and/or a solid-oxide electrolyzer) is arranged between neighboring separator plates of a cell stack. The sealing structure is constructed in at least two layers, including at least one insulating layer and at least one sealing layer.

Abstract: A process for isolating N-butylbenzenesulfonamide (NBBS) from biological material, the chemical synthesis of benzenesulfonamide derivatives, the use of NBBS and benzenesulfonamide derivatives for treating benign prostatic hyperplasia and/or prostate carcinomas the production of medicaments for the treatment thereof, and the use of NBBS and benzenesulfonamide derivatives as a lead substance in the development of active substances for treating benign prostatic hyperplasia and/or prostate carcinoma are provided.